Year: 2008
Type: article
Abstract: Metastasis, responsible for 90% of cancer patient deaths, is an inefficient process because many tumor cells die. The survival of metastatic tumor cells should be considered as a critical therapeutic target. This review provides a new perspective regarding the role of AKT in tumor survival, and the rationale to target AKT in anti‐metastasis therapies. J. Cell. Physiol. 218: 451–454, 2009. © 2008 Wiley‐Liss, Inc.
Source: Journal of Cellular Physiology
DOI: 10.1002/jcp.21616
Authors: Shijie Sheng, Meng Qiao, Arthur B. Pardee
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2094277516
